Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m

Takeda is to sell off a portfolio of over-the-counter and prescription drugs in the Near East, Middle East, and Africa for $200 million to Acino, as the Japanese company aims to pay off billions of dollars in debt following its merger with Shire earlier this year.